USANA Health Sciences (NYSE:USNA) Upgraded to Strong-Buy at StockNews.com

StockNews.com upgraded shares of USANA Health Sciences (NYSE:USNA) from a buy rating to a strong-buy rating in a report issued on Thursday morning.

Separately, DA Davidson decreased their target price on shares of USANA Health Sciences from $38.00 to $35.00 and set a “neutral” rating for the company in a research note on Wednesday, October 23rd.

USANA Health Sciences Price Performance

USNA stock opened at $34.71 on Thursday. The stock has a market capitalization of $661.57 million, a P/E ratio of 12.27, a P/E/G ratio of 1.25 and a beta of 0.89. USANA Health Sciences has a fifty-two week low of $34.15 and a fifty-two week high of $54.81. The business has a 50-day moving average of $37.98 and a 200-day moving average of $40.51.

USANA Health Sciences (NYSE:USNA) last issued its quarterly earnings results on Tuesday, October 22nd. The company reported $0.56 earnings per share for the quarter, topping the consensus estimate of $0.49 by $0.07. The company had revenue of $200.22 million during the quarter, compared to analysts’ expectations of $208.45 million. USANA Health Sciences had a net margin of 6.30% and a return on equity of 10.64%. During the same period last year, the business earned $0.59 EPS. Equities analysts expect that USANA Health Sciences will post 2.45 EPS for the current year.

Insider Activity

In related news, Director Gilbert A. Fuller sold 675 shares of the company’s stock in a transaction dated Monday, November 4th. The shares were sold at an average price of $37.71, for a total transaction of $25,454.25. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. 0.33% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On USANA Health Sciences

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Exchange Traded Concepts LLC grew its holdings in shares of USANA Health Sciences by 4.4% during the 3rd quarter. Exchange Traded Concepts LLC now owns 7,709 shares of the company’s stock valued at $292,000 after purchasing an additional 322 shares during the last quarter. Martingale Asset Management L P raised its holdings in USANA Health Sciences by 2.1% in the 3rd quarter. Martingale Asset Management L P now owns 16,732 shares of the company’s stock valued at $634,000 after buying an additional 340 shares during the last quarter. KBC Group NV boosted its position in USANA Health Sciences by 96.6% during the 3rd quarter. KBC Group NV now owns 1,056 shares of the company’s stock worth $40,000 after buying an additional 519 shares during the period. Safe Harbor Fiduciary LLC acquired a new position in USANA Health Sciences in the 3rd quarter valued at approximately $30,000. Finally, Public Sector Pension Investment Board raised its stake in shares of USANA Health Sciences by 5.4% during the second quarter. Public Sector Pension Investment Board now owns 24,270 shares of the company’s stock valued at $1,098,000 after acquiring an additional 1,242 shares during the last quarter. 54.25% of the stock is currently owned by institutional investors.

About USANA Health Sciences

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.